Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
115 hedge funds and large institutions have $311M invested in Surmodics in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 49 reducing their positions, and 11 closing their positions.
12,346% more call options, than puts
Call options by funds: $1.62M | Put options by funds: $13K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.76% less ownership
Funds ownership: 85.51% → 84.76% (-0.76%)
2% less funds holding
Funds holding: 117 → 115 (-2)
11% less capital invested
Capital invested by funds: $348M → $311M (-$36.6M)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
43% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 49
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.31M |
| 2 |
BlackRock
New York
|
+$1.47M |
| 3 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$774K |
| 4 |
ASRS
Arizona State Retirement System
Phoenix,
Arizona
|
+$465K |
| 5 |
State Street
Boston,
Massachusetts
|
+$459K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.94M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.83M |
| 3 |
CCMH
Cornerstone Capital Management Holdings
New York
|
-$522K |
| 4 |
Bank of New York Mellon
New York
|
-$511K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$401K |
SRDX Hedge Fund Activity: Q4 2017 in Review
115 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q4 2017, worth a combined $311M — down 11% from $348M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of SRDX and 9 opened new positions — a net loss of 2 holders — while 49 trimmed existing stakes and 28 added.
The largest buyer was Millennium Management, adding an estimated $2.31M. The largest seller was Wellington Management Group, cutting an estimated $2.94M.
- 115 institutional investors held Surmodics (SRDX) as of Q4 2017, down from 117 in Q3 2017.
- Funds reported $311M of Surmodics stock for Q4 2017, down 11% quarter-over-quarter.
- 9 funds opened new Surmodics positions in Q4 2017 and 11 closed out, a net change of -2 holders.
- The largest Surmodics buyer in Q4 2017 was Millennium Management, an estimated $2.31M added.
- The largest Surmodics seller in Q4 2017 was Wellington Management Group, an estimated $2.94M sold.
Based on aggregated 13F filings for Q4 2017.